HIV Medicine (HM)

HIV Medicine is a peer‑reviewed international medical journal focusing on original research, reviews, clinical guidelines, and feature articles relating to the treatment, diagnosis, and management of HIV/AIDS. Established in 1999, the journal serves as the official publication of the British HIV Association (BHIVA), the European AIDS Clinical Society (EACS), and the Deutsche AIDS‑Gesellschaft. It is published by Wiley‑Blackwell (John Wiley & Sons) and aims to disseminate rigorous scientific findings to clinicians and researchers involved in HIV care worldwide. The scope of HIV Medicine encompasses a broad range of topics including clinical outcomes of antiretroviral therapy, pharmacological studies, epidemiology, ethical considerations, preclinical research, and in‑vitro investigations. Its articles emphasize evidence‑based approaches to improve patient outcomes and advance knowledge in HIV medicine and infectious diseases. The journal’s audience includes infectious disease specialists, public health researchers, clinicians, and healthcare policymakers. With a strong emphasis on multidisciplinary research and clinical relevance, it contributes significantly to global HIV care strategies and medical practice.

HIV Medicine (HM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology (medical), Infectious Diseases, Health Policy, clinical, pharmacological, epidemiological, ethical, preclinical and in‑vitro studies, evidence‑based medicine for HIV care and treatment , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1464-2662, E-ISSN: 1468-1293, Established: 1999, Impact Factor: 3.2
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE